Cavanaugh Sarah

CIK 00017091131 companyHAMPTON, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001709113

Recent Transactions

33 trades

Award
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (right to buy)
2025-06-05+78,000→ 78,000 total
Award
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (right to buy)
2024-06-13+78,000→ 78,000 total
Sale
Celldex Therapeutics, Inc.$CLDX
Common Stock
2024-05-30$33.73/sh−20,853→ 1,860 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (Right to Buy)
2024-05-30−10,750→ 0 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (Right to Buy)
2024-05-30−10,103→ 0 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Common Stock
2024-05-30$2.78/sh+10,750→ 12,610 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Common Stock
2024-05-30$9.02/sh+10,103→ 22,713 total
Award
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (right to buy)
2023-06-15+75,000→ 75,000 total
Sale
Celldex Therapeutics, Inc.$CLDX
Common Stock
2022-08-18$36.38/sh−1,355→ 1,284 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Common Stock
2022-08-18$9.02/sh+1,355→ 2,639 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option
2022-08-18−1,355→ 10,103 total
Sale
Celldex Therapeutics, Inc.$CLDX
Common Stock
2022-08-17$36.73/sh−31,312→ 1,284 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Common Stock
2022-08-17$2.78/sh+31,312→ 32,596 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option
2022-08-17−31,312→ 10,750 total
Award
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (right to buy)
2022-06-16+73,000→ 73,000 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Common Stock
2021-12-08$10.38/sh+5,466→ 7,731 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (Right to Buy)
2021-12-08−1,857→ 11,458 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Common Stock
2021-12-08$9.02/sh+1,857→ 2,265 total
Sale
Celldex Therapeutics, Inc.$CLDX
Common Stock
2021-12-08$40.00/sh−7,323→ 408 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (Right to Buy)
2021-12-08−5,466→ 78,534 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Common Stock
2021-11-01$9.02/sh+5,018→ 6,793 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Common Stock
2021-11-01$2.78/sh+938→ 7,731 total
Sale
Celldex Therapeutics, Inc.$CLDX
Common Stock
2021-11-01$43.06/sh−901→ 2,528 total
Sale
Celldex Therapeutics, Inc.$CLDX
Common Stock
2021-11-01$41.62/sh−2,120→ 408 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (Right to Buy)
2021-11-01−5,018→ 13,315 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (Right to Buy)
2021-11-01−938→ 42,062 total
Sale
Celldex Therapeutics, Inc.$CLDX
Common Stock
2021-11-01$44.11/sh−4,302→ 3,429 total
Award
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (right to buy)
2021-06-17+56,000→ 56,000 total
Award
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (right to buy)
2020-06-18+84,000→ 84,000 total
Purchase
Celldex Therapeutics, Inc.$CLDX
Common Stock, par value $0.001 per share
2020-06-10$4.83/sh+1,050→ 1,367 total
Award
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (right to buy)
2019-06-19+43,000→ 43,000 total
Award
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (right to buy)
2018-06-13+275,000→ 275,000 total
Award
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (right to buy)
2017-06-15+65,000→ 65,000 total

Companies

Celldex Therapeutics, Inc.
SVP OF CORP AFFAIRS & ADMIN.
$CLDX

Recent Filings

Address

C/O CELLDEX THERAPEUTICS, INC. 53 FRONTAGE ROAD, SUITE 220

HAMPTON, NJ, 08827

View on SEC.gov